Skip to content
Home

Malaria: cause, transmission, life cycle, prevention and global impact

Comprehensive overview of malaria: the Plasmodium parasites, mosquito vectors, transmission routes, clinical features, diagnosis, treatment, prevention, history and global public‑health impact.

Overview
Malaria is an infectious disease caused by single‑celled parasites of the genus Plasmodium. It is transmitted most commonly when an infected female mosquito injects parasite stages into a human while feeding. The clinical spectrum ranges from a mild febrile illness to severe, life‑threatening disease with complications such as severe anaemia, respiratory distress and cerebral involvement. Malaria remains one of the major global public health concerns in many tropical and subtropical regions and is a leading cause of illness and death in young children and pregnant people in high‑transmission settings. For introductory material and definitions, see general references on malaria biology basic malaria information.

Image gallery

10 Images

Parasite species and biology

The organisms that cause human malaria are protozoan parasites of the genus Plasmodium. The principal human species historically recognised are P. falciparum, P. vivax, P. ovale and P. malariae, with a zoonotic species, P. knowlesi, identified as an additional cause of human infections in parts of Southeast Asia. These protozoa are single‑celled eukaryotes with complex life cycles involving distinct stages in a mosquito vector and in a vertebrate host. For background on protozoan organisms and single‑celled life forms see these resources protozoa overview and single‑celled life. Note the difference between protozoa and bacteria in cellular complexity and life history comparison with bacteria.

Life cycle and transmission

The Plasmodium life cycle alternates between a mosquito and a human host. Infective forms (sporozoites) are injected into the bloodstream by an infected female mosquito when it takes a blood meal. Sporozoites travel to the liver and mature, producing blood‑stage parasites that invade red blood cells and cause symptoms. Sexual forms of the parasite taken up by a mosquito complete development in the insect and render the mosquito infectious to the next human it bites. The mosquito vector is central to transmission and to control strategies; for general notes on vectors and vector biology see vector information.

Vectors and ecology

In most endemic regions, female mosquitoes of the genus Anopheles are the primary vectors of malaria. Only female mosquitoes feed on blood to obtain protein for egg development; males feed on nectar or plant sugars (nectar sources). Vector species vary in behaviour, breeding preferences and peak biting times; these factors determine how transmission occurs in a given place and influence which control measures are most effective. Historical and archived entomological sources may be consulted for changes in vector distributions archived vector data.

Other routes of transmission

Although mosquito bites are the dominant route, malaria can be transmitted in other ways when parasites are introduced directly into the bloodstream. These include congenital (maternal‑foetal) transmission, transfusion of infected blood blood transfusion, and contaminated injection equipment such as shared needles unsafe injections. Such non‑vector routes are relatively uncommon but important for blood safety and clinical practice, and they are considered in screening policies.

Clinical features, diagnosis and management

Early symptoms typically include fever, chills, headache, fatigue and muscle aches; symptoms may appear days or weeks after infection depending on species and exposure history. Some species (for example P. vivax and P. ovale) can form dormant liver stages that cause relapses weeks to months after the initial illness. Prompt diagnosis reduces the risk of progression to severe disease. Routine diagnosis is commonly made by microscopic examination of blood films or by rapid diagnostic tests that detect parasite antigens; specialised molecular tests are used in research and reference settings. Effective antimalarial medications exist and selection depends on the infecting species, local drug‑resistance patterns and the severity of illness. For clinical resources and treatment guidelines see authoritative references treatment guidance.

Prevention and control strategies

Prevention combines individual protection and community‑level interventions. Personal measures include long‑lasting insecticidal nets (LLINs), topical repellents, protective clothing and prompt care seeking for fever. Community and public health measures include indoor residual spraying with insecticides, larval source management where appropriate, effective case detection and treatment, and surveillance to detect outbreaks. Vaccine research has produced candidate vaccines and pilot implementation of partly effective vaccines in high‑risk areas has begun; vaccine use is being evaluated alongside other interventions. Successful control programmes typically integrate vector control, case management and surveillance with sustained funding and community engagement.

History, burden and challenges

Large reductions in malaria burden have been achieved in many places through coordinated control efforts, but the disease persists in parts of Africa, Asia, the Americas and Oceania. Challenges that complicate elimination include insecticide resistance in mosquitoes, antimalarial drug resistance in parasites, ecological change, population movements and gaps in health system coverage. Vulnerable groups include young children, pregnant people and those without access to prompt diagnosis and treatment. Global and national programmes emphasise surveillance, equitable access to tools and research into new interventions.

Public health advice and sources

  • Travelers to endemic areas should seek pre‑travel health advice on prevention, chemoprophylaxis and when to seek care.
  • Pregnant people and young children require particular attention because of higher risk of complications.
  • Blood services and clinical providers follow screening protocols to reduce transfusion and nosocomial transmission risks.

Readers seeking clinical guidance or policy details should consult national health agencies and recognised international public health authorities. The links embedded in this article direct to general topic pages and archived resources for background reading; they are placeholders for trusted reference material and programme guidance.

Word Origin

The disease name malaria is derived from Italian mal'aria ("bad air", which rises as a bad exhalation, also called miasma, especially from the swamps, and was held since antiquity to cause disease, especially in the case of alternating fever (febris intermittens)), from Latin mala "bad", and aer "air". The Italian term mal(a) aria is found in 1709 in a work extensively treating this disease by the physician Francesco Torti (1658-1741), a personal physician to Francesco II d'Este and Rinaldo d'Este.

Pathogen

List of human pathogens

Plasmodium

Incubation time

Malaria form

Typical rhythm of febrile seizures

P. falciparum

7-30 days (90 %)
longer (10 %)*

malaria tropica

irregular

P. malariae

16-50 days

malaria quartana

about 72 hours, 1 day fever then 2 days without fever

P. oval

12-18 dayslonger
(10 %)*

tertian malaria

about 48 hours, 1 day fever then 1 day without fever

P. vivax

12-18 dayslonger
(10 %)*

tertian malaria

about 48 hours, 1 day fever then 1 day without fever

P. knowlesi

10-12 days

malaria quotidiana

24 hours, every day fever

(* in case of insufficient malaria prophylaxis)

The pathogen belongs to the Apikomplexa. The pathogens Plasmodium falciparum, Plasmodium vivax, Plasmodium ovale, Plasmodium malariae and Plasmodium knowlesi, which can trigger various forms of malaria, are dangerous for humans.

In addition, Plasmodium can also cause semioval malaria. In multiple infections with the same or different plasmodia, the fever attacks can also be irregular. The otherwise regular typical alternating fever is absent, there is irregular and possibly permanent fever. Since the schizogonic cycle of P. knowlesi is 24 h, this infection manifests itself in malaria quotidiana with daily febrile attacks.

Life cycle

In the course of their life cycle, the pathogens of malaria, the plasmodia, change hosts. Humans serve as intermediate hosts. Mosquitoes, especially of the genus Anopheles, serve as the final host. The plasmodia reproduce in them.

In humans (asexual phase/schizogony)

After a person has been bitten by an infected Anopheles mosquito, it secretes several hundred sporozoites with its saliva, which contains anticoagulants. These are carried with the bloodstream to the liver, where they penetrate the spleen and, above all, the cells of the liver tissue, where they mature into the liver schizont. There they multiply (divide), called exoerythrocytic schizogony. This gives rise to up to 30,000 merozoites. The schizont dissolves and releases the merozoites gradually into the bloodstream enclosed in vesicles. In Plasmodium vivax and Plasmodium ovale, not all the merozoites go this route; a small proportion may survive undivided in the liver cell as hypnozoites. In this dormant state, they can remain undetected by the immune system for months to years. Due to an unknown stimulus, the hypnozoites mature into schizonts, which leads to characteristic relapses of malaria tertiana.

The merozoites enter the bloodstream and attach to receptor molecules of red blood cells, whereupon they can penetrate them and are enclosed within a membrane-limited, parasitophoric vacuole. With the infestation of red blood cells, erythrocytic schizogony begins. The merozoites then mature into a trophozoite. At this stage, the pathogen appears as a ring around its own food vacuole with a dark-colored, marginal nucleus. The trophozoite matures further into a schizonts that feeds primarily on glucose and hemoglobin. This produces heme, which, however, is immediately crystallized to hemozoin, since free heme is toxic to the trophozoite. After multiple division, 6 to 36 merozoites emerge from the schizonts, depending on the Plasmodium species. Due to their large quantity, these cause the erythrocyte to burst and are thus distributed in the blood plasma. There the merozoites can infect further erythrocytes and the asexual cycle begins again. After a short initial phase, the schizogony cycles proceed synchronously at regular intervals of 48 (Plasmodium vivax, ovale, falciparum, but the latter is unsynchronized) and 72 hours (Plasmodium malariae). The fever following the destruction of the erythrocyte accordingly occurs every 3 or 4 days (malaria tertiana and malaria quartana) due to the synchronization of this cycle. A small number of the merozoites go on to develop into their sexual forms, the gametocytes. These are then found in the blood, where they die again after some time (Plasmodium vivax: 1 day, Plasmodium falciparum: up to 22 days), unless they are ingested by an Anopheles mosquito. The male gametocytes are called microgametocytes, the female macrogametocytes.

In the mosquito (sexual phase/sporogony)

When a mosquito bites again, the gametocytes are absorbed into the mosquito. They develop into gametes in her intestine. The microgametes penetrate the macrogametes and a zygote develops. This changes, takes on an elongated shape and becomes motile (= mobile). this cell is now called an ookinet. It attaches itself between the tissue layers of the mosquito's intestine, where it transforms into an oocyst. Up to 1,000 new sporozoites develop in it. After their release, they migrate into the mosquito's salivary glands and are now ready for reinfection. The cycle in the Anopheles lasts between 8 and 16 days, depending on the outside temperature. A minimum temperature of 15 °C is required. Below this temperature, the cycle no longer occurs.

Human-to-human infection routes

Without the mosquito route, malaria can be transmitted from person to person via blood.

There are two known ways to do this:

Following the death of an 84-year-old woman on March 18, 2019, after surgery involving blood transfusions the previous February in Carinthia, it has been reported that malaria caused her death, according to prosecutors. Blood bags are traceable to donors. Those wishing to donate must declare foreign travel and are not allowed to donate within 6 months of returning from a malaria-affected area. Donated blood is not yet tested for malaria pathogens in Austria.

Questions and answers

Q: What is malaria?

A: Malaria is an infectious disease caused by a parasite that is spread by the bite of an infected mosquito. It can be deadly and kills many people each year.

Q: What causes malaria?

A: Malaria is produced by 4 species of the protozoal parasite Plasmodium, which are endemic in many tropical countries.

Q: How many cases of malaria occur globally each year?

A: According to WHO estimates (2011), between 149 and 274 million clinical cases and ~ 0.655 million deaths occur globally due to malaria each year, 90% of which are in Africa. This amounts to one malaria death every minute.

Q: How did India achieve near complete disappearance of the disease in 1960s?

A: In India, the National Malaria Eradication Programme (NMEP), started in 1958, achieved near complete disappearance of the disease in 1960s (from 75 million cases in 1950s to 0.1 million cases in 1960s).

Q: What type of organism is responsible for causing malaria?

A: The parasite that causes malaria is a protozoan called 'Plasmodium'. Protozoa are organisms with only one cell, but they are not bacteria; bacteria are smaller and simpler than protozoans.

Q: How do mosquitoes transmit Plasmodium into humans?

A: People usually get malaria from Anopheles or Culex mosquitoes; these mosquitoes act as vectors for the disease by injecting their saliva containing Plasmodium into humans when they bite them.

Q: Are there other ways people can catch malaria besides being bitten by a mosquito?

A: Yes, babies can get it while inside their mother (maternal-foetal transmission), people can also get it from a blood transfusion or using a needle that someone with the disease used before them.

Related articles

Author

AlegsaOnline.com Malaria: cause, transmission, life cycle, prevention and global impact

URL: https://en.alegsaonline.com/art/60945

Share

Sources